Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
2020 · New England Journal of Medicine · 962 citations
https://doi.org/10.1056/nejmoa1901814
T
Timothy D. McHugh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
430
Papers
20.9K
Citations
64
h-index
202
i10-index
Timothy D. McHugh is an academic researcher from The Royal Free Hospital. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Mycobacterium research and diagnosis & Pneumonia and Respiratory Infections. The author has an h-index of 64, co-authored 366 publications.
ORCID: 0000-0003-4658-8594Papers by this author
worksBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
2022 · New England Journal of Medicine · 507 citations
https://doi.org/10.1056/nejmoa2119430
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
2022 · New England Journal of Medicine · 318 citations
https://doi.org/10.1056/nejmoa2117166
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
2013 · The Lancet Respiratory Medicine · 215 citations
https://doi.org/10.1016/s2213-2600(13)70231-5
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
2020 · International Journal of Infectious Diseases · 204 citations
https://doi.org/10.1016/j.ijid.2020.02.049
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
2021 · International Journal of Infectious Diseases · 191 citations
https://doi.org/10.1016/j.ijid.2021.11.040
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat